Schizophrenia as a Health Disparity
By Thomas Insel on
Dr. Insel blogs about what epidemiological research in Sweden tells us about premature mortality experienced by people with serious mental illness and what we need to do to change that.
By Thomas Insel on
Dr. Insel blogs about what epidemiological research in Sweden tells us about premature mortality experienced by people with serious mental illness and what we need to do to change that.
By Thomas Insel on
Dr. Insel talks about how NIMH’s RAISE study is exploring an integrated, multi-component approach to health care for schizophrenia.
By Thomas Insel on
Dr. Insel reflects on the state of mental health care and research 50 years after President Kennedy’s special message to congress on mental health.
By Thomas Insel on
Dr. Insel responds to discussion from the National Advisory Mental Health Council concerning the need to balance research funding for basic science and mental health services.
By Thomas Insel on
Dr. Insel shares NIMH’s Top 10 Research Advances for 2011.
By Thomas Insel on
Dr. Insel describes how precision medicine may put us on the path to better diagnosis and treatment of mental disorders.
By Thomas Insel on
Two papers published this week in Nature provide the first maps of the molecular development of the human brain. Mapping brain development by changes in gene expression gives us a new level of precision and raises new possibilities for understanding the mechanisms of neurodevelopmental disorders.
By Thomas Insel on
Dr. Insel discusses World Mental Health Day and a new approach to meeting the shortage of mental health providers.
By Thomas Insel on
Dr. Insel discusses the implications of comorbidity among people with serious mental illness.
By Thomas Insel on
Dr. Insel discusses the promising future of psychiatry as it integrates new approaches discovered through neuroscience.
By Thomas Insel on
10 breakthroughs and events of 2010 which are changing the way we approach mental disorders.
By Thomas Insel on
NIMH/NIH is nurturing medications development via assays that probe new molecular targets relevant to mental disorders.